Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33957
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCrosswell, Howland E-
dc.contributor.authorLaCasce, Ann S-
dc.contributor.authorBartlett, Nancy L-
dc.contributor.authorStraus, David J-
dc.contributor.authorSavage, Kerry J-
dc.contributor.authorZinzani, Pier Luigi-
dc.contributor.authorCollins, Graham P-
dc.contributor.authorFanale, Michelle-
dc.contributor.authorFenton, Keenan-
dc.contributor.authorDong, Cassie-
dc.contributor.authorMiao, Harry-
dc.contributor.authorGrigg, Andrew P-
dc.date2023-
dc.date.accessioned2023-10-11T06:21:18Z-
dc.date.available2023-10-11T06:21:18Z-
dc.date.issued2023-10-05-
dc.identifier.citationHaematologica 2023-10-05en_US
dc.identifier.issn1592-8721-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33957-
dc.description.abstractNot available.en_US
dc.language.isoeng-
dc.titleBrentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleHaematologicaen_US
dc.identifier.affiliationBon Secours Hematology and Oncology, Bon Secours, St. Francis Health System, Greenville, SC.en_US
dc.identifier.affiliationDana-Farber Cancer Institute, Partners Cancer Care, Boston, MA.en_US
dc.identifier.affiliationSiteman Cancer Center, Washington University School of Medicine, St Louis, MO.en_US
dc.identifier.affiliationLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.en_US
dc.identifier.affiliationBritish Columbia Cancer Agency, Vancouver, BC.en_US
dc.identifier.affiliationIRCCS University Hospital of Bologna, Institute of Hematology "Seràgnoli," Bologna, Italy; Department of Specialized Medicine, Diagnostic and Experimental, University of Bologna, Bologna.en_US
dc.identifier.affiliationOxford University Hospitals NHS Foundation Trust, Oxford.en_US
dc.identifier.affiliationSeagen Inc., Bothell, WA.en_US
dc.identifier.affiliationTakeda Development Center Americas, Inc. (TDCA), Lexington, MA.en_US
dc.identifier.affiliationClinical Haematologyen_US
dc.identifier.doi10.3324/haematol.2023.283303en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37794803-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Dec 17, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.